Brydon L. Bennett - Concepedia

Author

Brydon L. Bennett

SignalRx Pharmaceuticals (United States)

Also Known As

B Bennett, B L Bennett, B. Bennett, B. L. Bennett, B.L Bennett, Brenner, David A., Brydon Bennett, Brydon L Bennett, Brydon L. Bennett

Publications

10.3K

Citations

H-Index

Concepts

All Affiliations

SignalRx Pharmaceuticals (United States)University of California San Diego Bristol-Myers Squibb (Switzerland)University of North Carolina at Chapel Hill Monash Medical Centre

About

Brydon L. Bennett is an author at SignalRx Pharmaceuticals (United States) specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	25	4.6K
2	Natural Sciences	2	2	2.1K
3	Education	1	1	19
4	Public Health	1	1	19
5	Allergy	1	1	75

Brydon L. Bennett

Publications

10.1K

Citations

H-Index

Page 1

	Year	Citations
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase Brydon L. Bennett, Dennis T. Sasaki, Brion W. Murray, Proceedings of the National Academy of Sciences	2001	2.5K
IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation Frank Mercurio, Hengyi Zhu, Brion W. Murray, Science ImmunologyMolecular BiologyInflammationSignaling PathwayCell Regulation	1997	2K
c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis Zuoning Han, David L. Boyle, Lufen Chang, Journal of Clinical Investigation Metalloproteinase ExpressionImmunologyPathologyCell DeathJoint Destruction	2001	771
Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain Véronique Baud, Zhanguo Liu, Brydon L. Bennett, Genes & Development	1999	456
IκB Kinase (IKK)-Associated Protein 1, a Common Component of the Heterogeneous IKK Complex Frank Mercurio, Brion W. Murray, Andrej Shevchenko, Molecular and Cellular Biology	1999	326
Inhibitor of nuclear factor ?B kinase ? is a key regulator of synovial inflammation Paul P. Tak, Daniëlle M. Gerlag, Karl R. Aupperle, Arthritis & Rheumatism	2001	232
The NF-κB Cascade Is Important in Bcl-xL Expression and for the Anti-Apoptotic Effects of the CD28 Receptor in Primary Human CD4+ Lymphocytes Ali Khoshnan, Charles Tindell, Isett Laux, The Journal of Immunology ApoptosisImmunologyImmune RegulationCell DeathCd28 Receptor	2000	218
JNK mediates hepatic ischemia reperfusion injury Tetsuya Uehara, Brydon L. Bennett, Steve T. Sakata, Journal of Hepatology HepatologyLiver PhysiologyImmunologyHepatology InflammationVascular Biology	2005	216
Role of IKK1 and IKK2 in Lipopolysaccharide Signaling in Human Monocytic Cells Maria A. O’Connell, Brydon L. Bennett, Frank Mercurio, Journal of Biological Chemistry	1998	184
A Pathogenic Role for c-Jun Amino-Terminal Kinase Signaling in Renal Fibrosis and Tubular Cell Apoptosis Y. Frank, Robert S Flanc, Greg H. Tesch, Journal of the American Society of Nephrology Jnk SignalingApoptosisRenal PathologyRenal InflammationPathology	2007	173

Page 1